▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #1021 by analyst upside · 2026-11-13
MDXG
MiMedx Group, Inc.
Healthcare · Market Cap $473M · P/E 0x
ANALYST PRICE TARGET
+116.0%
implied upside to consensus target
Current Price $3.24
Consensus Target $7.0
Bull Target $8.0
Bear Target $6.0
Analysts Covering 5
ANALYST CONSENSUS - BUY
Strong Buy
1
Buy
4
Hold
0
Sell
0
52-Week Low $3.03
52-Week High $7.63
YTD Return -50.0%
FUNDAMENTALS
Market Cap $473M
P/E Ratio (TTM) N/A
Forward P/E 30.4x
EPS (TTM) $-0.13
PEG Ratio 2.88
Dividend Yield N/A
Revenue (TTM) $304M
Profit Margin -6.3%
52-WEEK RANGE
52-Week Low $3.03
52-Week High $7.63
Current Price $3.24
Bear Target $6.0
Bull Target $8.0
● Now $3.24 ● Target $7.0
TRADING DATA
Avg Volume 1.3M
YTD Return -50.0%
Analyst Count 5
Consensus Buy
Upside to Target +116.0%
Last Updated 2026-11-13

ANALYST SUMMARY

MiMedx Group, Inc. (MDXG) is currently trading at $3.24 with a Wall Street consensus price target of $7.0, implying potential upside of 116.0% over the next 12 months. 5 analysts currently cover MDXG, with a consensus rating of Buy - 100% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $8.0, while the most cautious has a target of $6.0.

MDXG operates in the Healthcare sector with a market capitalisation of $473M. The stock is down 50.0% year-to-date and is currently trading near the lower end of its 52-week range of $3.03 – $7.63.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

CYH +19.1%
Community Health Systems, Inc.
$312M · P/E 8.8x · Hold
CRMD +222.3%
CorMedix Inc.
$385M · P/E 2.4x · Strong Buy
VMD +31.7%
Viemed Healthcare, Inc.
$345M · P/E 24.0x · Buy
HSTM +27.3%
HealthStream, Inc.
$866M · P/E 40.4x · Underperform
INFU +25.1%
InfuSystem Holdings, Inc.
$296M · P/E 32.9x · Buy

RECENT ANALYST CALLS

Upgrade/downgrade history for MDXG, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Craig-Hallum - Reiterated
Buy → Buy 2026-08-27 Building track record
Cantor Fitzgerald reit
Overweight → Overweight 2026-08-17 40% win rate (10 calls)
Citizens - Reiterated
Market Outperform → Market Outperform 2026-04-30 Building track record
Citizens - Reiterated
Market Outperform → Market Outperform 2026-04-20 Building track record
Craig-Hallum - Reiterated
Buy → Buy 2026-04-17 Building track record
Citizens ● Initiated
Market Outperform 2026-02-23 Building track record
Cantor Fitzgerald - Reiterated
Overweight → Overweight 2026-02-17 40% win rate (10 calls)
Lake Street - Reiterated
Buy → Buy 2026-01-20 27% win rate (11 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
59
out of 100
Coverage depth
14/30
Consensus clarity
18/30
Vote unanimity
25/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →